Shandong Sinobioway Biomedicine Co.,Ltd. Posted 21.4 Million Yuan Net Loss in First Quarter of 2023

Shandong Sinobioway Biomedicine Co.,Ltd. (山东未名生物医药股份有限公司) (002581.SZ) reported a net loss of 21.4 million yuan in the first quarter of 2023, reversing a net profit of 4.8 million yuan for the same period in the previous year.

Meanwhile, the company posted 75.6 million yuan in revenue, down 13.5% year-on-year.

At the end of the reporting period, it had 2.8 billion yuan in total assets and 318 million yuan in total liabilities, with a liability-to-asset ratio of 11.5%.